CiQUS addresses challenges in Biological and Medicinal Chemistry, New functional Materials and Synthetic Technologies.
We host 19 research groups (11 ERC projects, including 4 ERC-PoC), which obtain 7 MEUR/year in competitive funds (2017-2020) and an average Impact Factor of 7,4 (JCR) during the same period. Other outputs: 21 patents granted, 2 licences and 4 spin-offs.

- BIOMED: i) Drug & nuclei acid delivery; ii) Functional materials (nanoparticles, MOFs…) for drug delivery, theragnostic or cell reprogramming; iii) Bio-supramolecular chemistry & nanotechnology at the interface with cell biology.
- MATERIALS: i) Metal-Carbon Hybrid Nanostructures for Spintronics and Energy-related Applications; ii) Tailored Nanographenes; iii) Magnetic, electronic & thermal properties; iv) Chirality. Stimuli-Responsive polymers; v) Organic, inorganic & metallo-organic materials.
- SYNTHESIS: i) Innovative catalytic methodologies; ii) Selective and sustainable synthetic methodologies; iii) Catalytic transformations in biological media; iii) Theoretical and Computational Chemistry.

We are currently seeking best-in-class collaboration partners for our publications listed in the tab Opportunities. We want to invite you to cooperate with us, so please repond to any of the opportunities by submitting one or more proposals. Our team will directly evaluate them and get back to you with a response. Please provide as much detailed non-confidential information as possible to facilitate the engagement process.